Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.660
-0.290 (-7.34%)
At close: Oct 2, 2026, 4:00 PM EDT
3.680
+0.020 (0.55%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Jaguar Health Employees
Jaguar Health had 47 employees as of December 31, 2025. The number of employees decreased by 2 or -4.08% compared to the previous year.
Employees
47
Change (1Y)
-2
Growth (1Y)
-4.08%
Revenue / Employee
$591,809
Profits / Employee
-$1,115,319
Market Cap
1.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -2 | -4.08% |
| Dec 31, 2024 | 49 | 0 | - |
| Dec 31, 2023 | 49 | -11 | -18.33% |
| Dec 31, 2022 | 60 | 8 | 15.38% |
| Dec 31, 2021 | 52 | 18 | 52.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Genprex | 13 |
| Artelo Biosciences | 7 |
| Oragenics | 3 |
| Silo Pharma | 3 |
| Matinas BioPharma Holdings | 2 |
JAGX News
- 17 hours ago - Jaguar Health Announces a Special Stock Dividend - Accesswire
- 4 days ago - Jaguar Health Proxy statement: Proxy filing - Filings
- 4 days ago - Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting - Accesswire
- 11 days ago - Jaguar Health receives fee waivers from FDA - TheFly
- 11 days ago - Jaguar Health Receives Fee Waivers from FDA - Accesswire
- 15 days ago - Jaguar Health Proxy statement: Proxy filing - Filings
- 18 days ago - Jaguar Health announces 1-for-15 reverse stock split - TheFly
- 18 days ago - Jaguar Health, Inc. Announces Reverse Stock Split - Accesswire